Cyclogyl (Cyclopentolate)

What is the active ingredient in Cyclogyl? Cyclopentolate hydrochloride What are the inactive ingredients? For a complete list of inactive ingredients, click here or check the product packaging. Interactions Cyclogyl eye drops could interact with the following medications: Carbachol, Pilocarpine, Ophthalmic cholinesterase inhibitors

Who should avoid using Cyclogyl? Do not use Cyclogyl if you have a known allergy to any of the ingredients., Do not use Cyclogyl if you have untreated narrow-angle glaucoma. What are the risks? Cyclogyl can cause central nervous system disturbances, especially in younger patients., If you are pregnant, breastfeeding, or considering becoming pregnant, talk to your doctor about the risks of using Cyclogyl.

What are the potential side effects of Cyclogyl? Increased intraocular pressure, Burning, Photophobia, Blurred vision, Irritation, Hyperemia, Conjunctivitis, Blepharoconjunctivitis, Punctate keratitis, Synechiae, Psychotic disturbances, Ataxia, Incoherent speech, Restlessness, Hallucinations, Hyperactivity, Seizures, Disorientation, Skin rash, Drowsiness, Tachycardia, Hyperpyrexia, Vasodilation, Urinary retention, Diminished gastrointestinal motility, Decreased salivation Other Considerations Compare our Cyclogyl eye drops price at Canada Pharmacy to your local pharmacy. References: Fact Table Formula C17H25NO3 License US: FDA Bioavailability OMP: less than 10% Legal status RX Only Chemical Name Cyclopentolate Elimination half-life 111 minutes Dosage (Strength) 0.5%, 1%, 2% Pregnancy Risk not ruled out Brands Cyclogyl Protein binding - PubChem CID 2905 MedlinePlus a616014 ChEBI 4024 ATC code S01FA04 DrugBank DB00979 KEGG D07759 Routes of administration Ophthalmic Alex Covey studies chemistry and microbiology as an undergraduate before moving on to pharmacy school and completing his Pharm D.  His professional focus is on early phase clinical research but also has background experience in inpatient hospital, community pharmacy, and specialty compounding.Read More....